Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 205

Cited In for PubMed (Select 17211407)

1.

Dual-Mode HDAC Prodrug for Covalent Modification and Subsequent Inhibitor Release.

Daniel KB, Sullivan ED, Chen Y, Chan JC, Jennings PA, Fierke CA, Cohen SM.

J Med Chem. 2015 Jun 11;58(11):4812-21. doi: 10.1021/acs.jmedchem.5b00539. Epub 2015 Jun 2.

PMID:
25974739
2.

Epigenetics and pharmacology.

Stefanska B, MacEwan DJ.

Br J Pharmacol. 2015 Jun;172(11):2701-4. doi: 10.1111/bph.13136.

PMID:
25966315
3.

Targeting histone deacetylases: perspectives for epigenetic-based therapy in cardio-cerebrovascular disease.

Wang ZY, Qin W, Yi F.

J Geriatr Cardiol. 2015 Mar;12(2):153-64. doi: 10.11909/j.issn.1671-5411.2015.02.010. Review.

4.

Variable active site loop conformations accommodate the binding of macrocyclic largazole analogues to HDAC8.

Decroos C, Clausen DJ, Haines BE, Wiest O, Williams RM, Christianson DW.

Biochemistry. 2015 Mar 31;54(12):2126-35. doi: 10.1021/acs.biochem.5b00010. Epub 2015 Mar 20.

PMID:
25793284
5.

HDAC4 as a potential therapeutic target in neurodegenerative diseases: a summary of recent achievements.

Mielcarek M, Zielonka D, Carnemolla A, Marcinkowski JT, Guidez F.

Front Cell Neurosci. 2015 Feb 24;9:42. doi: 10.3389/fncel.2015.00042. eCollection 2015. Review.

6.

Targeting histone deacetylases: a novel approach in Parkinson's disease.

Sharma S, Taliyan R.

Parkinsons Dis. 2015;2015:303294. doi: 10.1155/2015/303294. Epub 2015 Jan 28. Review.

7.

Direct but no transgenerational effects of decitabine and vorinostat on male fertility.

Kläver R, Sánchez V, Damm OS, Redmann K, Lahrmann E, Sandhowe-Klaverkamp R, Rohde C, Wistuba J, Ehmcke J, Schlatt S, Gromoll J.

PLoS One. 2015 Feb 18;10(2):e0117839. doi: 10.1371/journal.pone.0117839. eCollection 2015.

8.

Photoaffinity labeling in target- and binding-site identification.

Smith E, Collins I.

Future Med Chem. 2015 Feb;7(2):159-83. doi: 10.4155/fmc.14.152.

9.

Valproic acid as a potential inhibitor of Plasmodium falciparum histone deacetylase 1 (PfHDAC1): an in silico approach.

Elbadawi MA, Awadalla MK, Hamid MM, Mohamed MA, Awad TA.

Int J Mol Sci. 2015 Feb 11;16(2):3915-31. doi: 10.3390/ijms16023915.

10.

Preclinical antitumor activity of ST7612AA1: a new oral thiol-based histone deacetylase (HDAC) inhibitor.

Vesci L, Bernasconi E, Milazzo FM, De Santis R, Gaudio E, Kwee I, Rinaldi A, Pace S, Carollo V, Giannini G, Bertoni F.

Oncotarget. 2015 Mar 20;6(8):5735-48.

11.
12.

The promise and perils of HDAC inhibitors in neurodegeneration.

Didonna A, Opal P.

Ann Clin Transl Neurol. 2015 Jan;2(1):79-101. doi: 10.1002/acn3.147. Epub 2014 Dec 3. Review.

13.

Biological targets and mechanisms of action of natural products from marine cyanobacteria.

Salvador-Reyes LA, Luesch H.

Nat Prod Rep. 2015 Feb 26;32(3):478-503. doi: 10.1039/c4np00104d.

PMID:
25571978
14.

A global assessment of cancer genomic alterations in epigenetic mechanisms.

Shah MA, Denton EL, Arrowsmith CH, Lupien M, Schapira M.

Epigenetics Chromatin. 2014 Dec 4;7(1):29. doi: 10.1186/1756-8935-7-29. eCollection 2014.

15.

A combined experimental and computational investigation on the unusual molecular mechanism of the Lossen rearrangement reaction activated by carcinogenic halogenated quinones.

Shan GQ, Yu A, Zhao CF, Huang CH, Zhu LY, Zhu BZ.

J Org Chem. 2015 Jan 2;80(1):180-9. doi: 10.1021/jo5022713. Epub 2014 Dec 17.

PMID:
25470188
16.

Specific inhibition of histone deacetylase 8 reduces gene expression and production of proinflammatory cytokines in vitro and in vivo.

Li S, Fossati G, Marchetti C, Modena D, Pozzi P, Reznikov LL, Moras ML, Azam T, Abbate A, Mascagni P, Dinarello CA.

J Biol Chem. 2015 Jan 23;290(4):2368-78. doi: 10.1074/jbc.M114.618454. Epub 2014 Dec 1.

PMID:
25451941
17.

Foxk proteins repress the initiation of starvation-induced atrophy and autophagy programs.

Bowman CJ, Ayer DE, Dynlacht BD.

Nat Cell Biol. 2014 Dec;16(12):1202-14. doi: 10.1038/ncb3062. Epub 2014 Nov 17.

18.

HDAC-inhibitor (S)-8 disrupts HDAC6-PP1 complex prompting A375 melanoma cell growth arrest and apoptosis.

Balliu M, Guandalini L, Romanelli MN, D'Amico M, Paoletti F.

J Cell Mol Med. 2015 Jan;19(1):143-54. doi: 10.1111/jcmm.12345. Epub 2014 Nov 6.

19.

The role of dietary histone deacetylases (HDACs) inhibitors in health and disease.

Bassett SA, Barnett MP.

Nutrients. 2014 Oct 15;6(10):4273-301. doi: 10.3390/nu6104273.

20.

Vorinostat downregulates CD30 and decreases brentuximab vedotin efficacy in human lymphocytes.

Hasanali ZS, Epner EM, Feith DJ, Loughran TP Jr, Sample CE.

Mol Cancer Ther. 2014 Dec;13(12):2784-92. doi: 10.1158/1535-7163.MCT-14-0593. Epub 2014 Oct 15.

PMID:
25319394
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk